Photoleukomelanodermatitis Of Kobori

Watchlist
Retrieved
2021-01-18
Source
Trials
Genes
Drugs

Photoleukomelanodermatitis of Kobori is a cutaneous condition, a dyschromic drug eruption that occurs after ingestion of afloqualone, thiazides or tetracyclines, followed by exposure to sunlight.

See also

  • Leukotriene receptor antagonist-associated Churg–Strauss syndrome
  • List of cutaneous conditions